Georgetown study says surprise-medical-bill protections could raise insurance premiums in Kentucky and beyond

A Georgetown University study highlighted in a LEX18 report on Wednesday says a law intended to protect patients from surprise medical bills may be contributing to higher insurance costs. The study’s central finding, as described by the outlet, is that the policy goal of limiting unexpected patient charges can be offset if the changes alter how healthcare bills are priced and settled across the broader system.

The LEX18 report frames the issue around the tradeoff between consumer protections and insurer cost exposure. While the law is meant to make healthcare more predictable for patients, the analysis cited by the report indicates that the costs created elsewhere in the payment process can be passed along, including through premium increases.

For Kentuckians shopping for or renewing health insurance, the practical stakes are timing and household budgets. Premium changes typically show up at renewal, meaning policyholders can feel system-level adjustments even if the law’s stated purpose is to shield them from unexpected out-of-pocket charges at the moment of care.

The Georgetown analysis discussed in the LEX18 article points to the idea that rules governing surprise-billing situations can affect provider billing behavior, payer reimbursement, or payment negotiations. Those system-level shifts, in turn, can influence what insurers charge to cover anticipated expenses, according to the report’s description of the study’s conclusions.

The LEX18 story does not indicate that the law is failing in its stated patient-protection objective in every case. Instead, it emphasizes that the same policy mechanism can have wider cost consequences, which may surface in premium rates rather than in the specific “surprise bill” situations the law was designed to address.

As Kentucky regulators, insurers, and employers continue to set plan costs for upcoming coverage periods, the Georgetown findings described by LEX18 add another data point to how lawmakers and stakeholders evaluate the downstream effects of healthcare payment rules. The next step for affected parties is to review the study’s methods and assumptions and assess how insurers and providers are applying the law in practice.